We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Industry

DiaSorin Enters Indian IVD Market

DiaSorin continues its expansion plan in Asia through the establishment of a Joint Venture Company with local partner Trivitron Healthcare, an Indian medical technology company focused on manufacturing and distribution, with solutions in the in vitro diagnostics business. More...
01 Aug 2012

Life Technologies Acquires Pinpoint Genomics and Lung Cancer Test

Life Technologies has acquired Pinpoint Genomics and its early-stage non-small-cell lung cancer test that can help doctors identify those early-stage patients at high risk for progression to late-stage disease. More...
25 Jul 2012

IVD Market Exceeded USD 50 Billion in 2011

AACC 2012: A market research company reports that the world market for in vitro diagnostics is estimated at USD 50.9 billion for 2011. More...
18 Jul 2012

Thermo Fisher Scientific to Acquire Transplant Diagnostics Leader One Lambda

Thermo Fisher Scientific has signed a definitive agreement to acquire One Lambda, pioneer and global leader in transplant diagnostics, for USD 925 million in cash. More...
18 Jul 2012

Carl Zeiss Licenses Digital Pathology from Olympus

Carl Zeiss Microscopy and Olympus America have signed a nonexclusive worldwide licensing agreement allowing Carl Zeiss to access a portfolio of patents held by Olympus in the field of digital pathology and virtual microscopy. More...
17 Jul 2012

HTG Molecular Diagnostics Granted License for Breast Cancer Markers

HTG Molecular Diagnostics has been granted a nonexclusive license by Merck to develop, manufacture, and commercialize breast cancer diagnostic tests. More...
16 Jul 2012

Epigenomics Signs Nonexclusive Licensing Agreement for Septin9

Epigenomics, a cancer molecular diagnostics company, signed a nonexclusive licensing agreement for its DNA methylation biomarker Septin9 with Companion Dx Reference Lab. More...
09 Jul 2012
New
Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
Automated Blood Typing System
IH-500 NEXT
New
Chemistry Analyzer
MS100
New
Tabletop Centrifuge
Mikro 185


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.